Measuring adherence in a hypertension clinical trial

European Journal of Cardiovascular Nursing

Volumn 2, Issue 3, 2003, Pages 219-228

  Hamilton, Glenys A ^a,b,c  

^a UNIVERSITY OF OSLO   (Norway)

^b Univ of MA Medical Center ^*  (United States)

^c UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

Adherence (compliance); Counselling; Hypertension; Measurement of adherence; Medication taking; Nursing interventions; Tailoring

Indexed keywords

PLACEBO; POTASSIUM;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT MONITORING; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SELF REPORT; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; DIRECTLY OBSERVED THERAPY; DOUBLE-BLIND METHOD; DRUG MONITORING; DRUG THERAPY, COMPUTER-ASSISTED; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; POTASSIUM; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS; STATISTICS, NONPARAMETRIC;

EID: 0141793779     PISSN: 14745151     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-5151(03)00058-6     Document Type: Article

References (59)

1. Hill M., Berk R.A. Psychological barriers to hypertension therapy adherence: instrument development and preliminary psychometric evidence. Cardiovasc Nurs. 31:(6):1995;37-43.
2. Burke L.E., Dunbar-Jacob J. Adherence to medication, diet, and activity recommendations: from assessment to maintenance. J Cardiovasc Nurs. 9:(2):1995;62-79.
3. Fogarty J.S. Reactance theory and patient non-compliance. Soc Sci Med. 45:(8):1997;1277-1288.
4. Hamilton GA. State of the Science Paper, commissioned by the Case Management Society of America, Council for Case Management Accountability. Patient adherence, outcome indicators and measurement in Case Management Health Care, 1999.
5. Hays R.D., DiMatteo M.R. Key issues and suggestions for patient compliance assessment: sources of information, focus of measures, and nature of response options. J Compl Health Care. 2:(1):1987;37-53.
6. Kruse W., Weber E. Dynamics of drug regimen compliance-its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol. 38:1990;561-565.
7. Rand C. Issues in the measurement of adherence. In: Schumaker, Schron, Ockene, editors. The handbook of health behavior change. New York: Springer Publishing Co, 1990. p. 102-10.
8. Ryan P., Lauver D.R. The efficacy of tailored interventions. IMAGE, J Nurs Scholarship. 34:(4):2002;331-337.
9. Haynes R.B., McKibbon K.A., Kanani R. Systematic review of randomised trial of interventions to assist patients to follow prescriptions for medication. The Lancet. 348:1996;383-386.
10. Hill M.N. Adherence to antihypertensive therapy. Izzo J.L., Black S.r. Hypertension primer. 2nd ed :1999;348-351 American Heart Association, Dallas, Texas. The essentials of high blood pressure, basic science, population science, and clinical management.
11. Preventing stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). J Am Med Assoc. 265:1991;3255-3264.
12. Grimm H., Grandits G.A., Cutlet J.A., Stewart A.L., McDonald R.H., Svendsen K., et al. Liebson PR for the THOMHS research group. Relationships of quality of life measures to long-term lifestyle and drug treatment in the treatment of mild hypertension study (THOMHS). Arch Intern Med. 157:1997;638-648.
13. Hill M.N., Becker D.M. Roles of nurses and health workers in cardiovascular health promotion. Am J Med Sci. 310:(Suppl 1):1995;S123-126.
14. Hill M.N., Bone L.R., Hilton S.C., Roary M.C., Kelen G.D., Levine D.M. A clinical trial to improve high blood pressure care in young urban black men: recruitment, follow-up and outcomes. Am J Hypertension. 12:(6):1999;548-554.
15. Working Group on Health Education and High Blood Pressure Control, National High Blood Pressure Education Program. The physician's guide: Improving adherence among hypertensive patients. Bethesda, MD. US Department of Health and Human Services, NHLBI, 1987.
16. Binstock M.L., Franklin K.L. A comparison of compliance techniques on the control of high blood pressure. Am J Hypertension. 1:(3 part 3):1988;192S-194SA.
17. Uemura K., Pisa Z. Trends in cardiovascular disease mortality in industrial countries since 1950. World Health Stat Q. 41:1988;155-168.29.
18. Deckers J.W. Towards prevention, and not just postponement of, atherosclerotic disease. Eur Heart J. 23:(10):2002;771-772. Editorial.
19. Marquas-Vidal P., Tuomilehto J. Hypertension awareness, treatment and control in the community: is the 'rate of halves' still valid? J Human Hypertension. 11:1997;213-220.
20. Thom T.J., Roccella E.J. Trends in blood pressure control and mortality. Izzo J.L., Black S.r. Hypertension primer. 2nd ed :1999;268-270 American Heart Association, Dallas, Texas. The essentials of high blood pressure, basic science, population science, and clinical management.
21. Murray CJL, Lopez (Eds.). The global burden of disease. a comprehensive assessment of morbidity and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. World Health Organization. Boston: Harvard University Press; 1996.
22. Colhoun H.M., Dong W., Poulter N.R. Blood pressure screening, management and control in England: results from the health survey for England 1994. J Hypertension. 16:1998;747-752.
23. Mulrow P.J. Hypertension A worldwide epidemic. Izzo J.L., Black S.r. Hypertension primer. 2nd ed :1999;271-273 American Heart Association, Dallas, Texas. The essentials of high blood pressure, basic science, population science, and clinical management.
24. Cooper R.S. Geographic patterns of hypertension: a global perspective. Izzo J.L., Black S.r. Hypertension primer. 2nd ed :1999;224-225 American Heart Association, Dallas, Texas. The essentials of high blood pressure, basic science, population science, and clinical management.
25. Burt V.L., Cutler J.A., Higgins M., Horan M.J., Labarthe D., Whelton P., et al. Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population. Data from the Health Examination Surveys, 1960 to 1991. Hypertension. 26:1995;60-69.
26. Yenney SL, Behrens RA. Health promotion and business coalitions. US Chamber of Commerce, 1984.
27. Stewart A.L., Greenfield S., Hays R.D., Wells K., Rogers W.H., Berry S.D. Functional status and well-being of patients with chronic conditions. Results from the medical outcomes study. J Am Med Assoc. 262:1989;907-913.
28. Krall RL. Interaction of compliance and patient safety. In: Cramer, Spilker, editors. Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991. p. 19-26.
29. British Medical Journal. Principles of the Declaration of Helsinki. 1964;ii:177.
30. Becker MH. Theoretical models of adherence and strategies for improving adherence. In: Schumaker, Schron, Ockene, editors. The handbook of health behavior change. New York: Springer Publishing Co, 1990. p. 5-43.
31. Cameron C. Patient compliance: recognition of factors involved and suggestions for promoting compliance with therapeutic regimens. J Adv Nur. 24:1996;244-250.
32. Cramer JA. Overview of methods to measure and enhance patient compliance. In: Cramer, Spilker, editors. Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991. p. 3-10.
33. Given C.W., Given B.A., Coyle B.W. Prediction of patient attrition from experimental behavioral interventions. Nur Res. 34:1985;293-298.
34. Levine D.M., Bone L. The impact of a planned health education approach on the control of hypertension in a high risk population. J Human Hypertension. 4:1990;317-321.
35. Prochaska JO, Redding CA, Evers KE. The transtheoretical model and stages of change. In: Glanz, Lewis, Rimer, editors. 2nd ed. Health behavior and health education: theory, research and practice. San Francisco: Jossey-Bass, 1997. p. 60-84.
36. Becker M.H. The Health belief model and personal health behavior. 1974;Thorofare, NJ.
37. Becker M.H., Maiman L.A. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care. 13:1975;10-24.
38. Rosenstock I.M. Enhancing patient compliance with health recommendations. Pediatr Health Care. 2:(2):1998;67-72.
39. Ajzen L., Fishbein M. Understanding attitudes and predicting social behavior. 1980;Prentice-Hall, Englewood Cliffs, NJ.
40. Hamilton GA. A multivariate approach to compliance in hypertension. Unpublished Dissertation, Boston University, 1982.
41. Hamilton G.A., Roberts S.J., Johnson J.M., Tropp J.R., Anthony-Odgren D., Johnson B. Increasing adherence in patients with primary hypertension: an intervention. Health Values. 17:(1):1993;3-11.
42. Sherbourne C.D., Hays R.D., Ordway L., DiMatteo M.R., Kravitz R.L. Antecedents of adherence to medical recommendations: results from the medical outcomes study. J Behav Med. 15:(5):1992;447-468.
43. DiMatteo M.R., Sherbourne C.D., Hays R.D., Ordway L., Kravitz R.L., McGlynn E.A., et al. Physicians' charcteristics influence patients' adherence to medical treatment: results from the medical outcome study. Health Psychol. 12:(2):1993;93-102.
44. ACT Co-operative Agreement - Adherence in Clinucal Trials: Results of the ACT Cooperative Agreement Society for Clinical Trials, 19th Annual Meeting, Atlanta, GA, May 17-20, 1998.
45. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-report measure of medication adherence. Med Care. 24:(1):1986;67-74.
46. Shea S., Misra D., Ehrlich M.H., Field L., Francis C.K. Correlates of nonadherence to hypertension measurement in an inner-city population. Am J Public Health. 82:(12):1992;1607-1612.
47. Haynes R.B., Sackett D.L., Gibson E.S., Taylor D.W., Hackett B.C., Roberts R.S., et al. Improvement of medication compliance in uncontrolled hypertension. Lancet. 1:1976;1265-1268.
48. Matsayuma J.R., Mason B.J., Jue S.G. Pharmacists' interventions using an electronic medication-event device's adherence data versus pill counts. Ann Paharmacotherapy. 27:1993;851-855.
49. Straka R.J., Fish J.T., Benson S.R., Suh J.T. Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug. Pharmacotherapy. 17:(1):1997;126-132.
50. Caron H.S. Compliance: the case for objective measurement. J Hypertension. 3:(Suppl. 1):1985;11-17.
51. DeGeest S., Borgermans L., Gemoets H., Abraham I., Vlaminick H., Evers G., et al. Incidence, determinants and consequences of sub-clinical non-compliance with immunosuppressive therapy in renal transplant. Transplantation. 59:1995;340-347.
52. Spilker B. Methods of assessing and improving patienr compliance in clinical trials. In: Cramer JA, Spilker, editors. Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991. p. 47-56.
53. Rudd P., Ahmed A., Zachary V., Barton C., Bonduelle D. Improved compliance measures: applications in an ambulatory hypertensive drug trial. Clin Pharmacol Therapeutics. 48:(6):1992;676-685.
54. Guerrero D., Rudd P., Bryant-Kosling C., Middleton B.F. Antihypertensive medication taking: investigation of a simple regimen. Am J Hypertension. 6:1993;586-592.
55. Vander Stichle R. Measure of patient compliance and the interpretation of randomized clinical trials. Eur J Clin Pharm. 41:1991;27-35.
56. Rand C.S., Wise R.A. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med. 149:1994;S69-76.
57. Steele D.J., Jackson T.C., Gutmann M.C. Have you been taking your pills? The adherence-monitoring sequence in the medical interview. J Fam Pract. 30:1990;294-299.
58. Dunbar-Jacob J., Dwyer K., Dunning J. Compliance with anti-hypertensive regimen: a review of the research in the 1980s. Ann Behav Med. 13:(1):1991;31-39.
59. Roter D.L., Hall J.A., Merisca R., Nordstrom B., Cretin D., Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 36:(8):1998;1138-1161.